| Serotonin inhibits gastric acid secretion through a 5-hydroxytryptamine1-like receptor in the rat. | |
| | |
MedLine Citation:
|
PMID: 7932163 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
5-Hydroxytryptamine (serotonin, 5-HT) is released from the gastrointestinal tract by vagal stimulation. This biogenic amine produces many alterations in gastric functional parameters, including inhibition of gastric acid secretion. This study was designed to characterize the 5-HT receptor subtype modulating gastric acid secretion. In urethane-anesthetized acute gastric fistula rats, systemic 5-HT (3.5 mumol/kg i.v.) inhibited acid output stimulated by pentagastrin infusion by 58%. Close gastric intra-arterial (i.a.) injection of methysergide, methiothepin, metergoline or spiperone but not tropisetron, renzapride or ritanserin was effective in reversing 5-HT-induced inhibition of acid secretion. Close i.a. administration of the potent 5-HT1A/1B antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine displayed partial agonist properties in this model, but did not antagonize 5-HT-induced inhibition of acid output. In a study of 5-HT agonists given close i.a. to the gastric circulation, 5-HT (0.88 mumol/kg) inhibited acid secretion by 48%. A 3-fold higher dose (2.6 mumol/kg) of the general 5-HT1 agonist, 5-carboxamidotryptamine (5-CT), was needed to inhibit acid secretion significantly. In contrast, neither the selective 5-HT1A agonist (+-)-8-hydroxy-2-(n-dipropylamino)-tetralin nor 5-HT2 agonist (+-)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane (0.88 or 2.6 mumol/kg) attenuated gastric acid secretion. Thus, the data suggest that the site mediating inhibition of acid secretion by exogenous 5-HT belongs to the 5-HT1 family, but may not be of the 5-HT1A subtype. |
| | |
Authors:
|
K J LePard; R L Stephens |
Related Documents
:
|
3932083 - The action of two mast cell stabilising agents and verapamil on rat gastric acid secret... 11825643 - Multiple regulation of peptide yy secretion in the digestive tract. 2048723 - Potential interference of hydrogen peroxide in the 2,2'-bicinchoninic acid protein assay. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of pharmacology and experimental therapeutics Volume: 270 ISSN: 0022-3565 ISO Abbreviation: J. Pharmacol. Exp. Ther. Publication Date: 1994 Sep |
Date Detail:
|
Created Date: 1994-11-07 Completed Date: 1994-11-07 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0376362 Medline TA: J Pharmacol Exp Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1139-44 Citation Subset: IM |
Affiliation:
|
Department of Physiology, College of Medicine, Ohio State University, Columbus. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Gastric Acid / secretion* Gastric Mucosa / drug effects, secretion Male Pentagastrin / antagonists & inhibitors, pharmacology Rats Rats, Sprague-Dawley Receptors, Serotonin / physiology* Serotonin / physiology* Serotonin Agonists / pharmacology Serotonin Antagonists / pharmacology |
| Grant Support | |
ID/Acronym/Agency:
|
DK 42880/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Receptors, Serotonin; 0/Serotonin Agonists; 0/Serotonin Antagonists; 50-67-9/Serotonin; 5534-95-2/Pentagastrin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cocaine effects on pulsatile secretion of ACTH in men.
Next Document: Molybdate depletes hepatic 3-phosphoadenosine 5-phosphosulfate and impairs the sulfation of acetamin...